What is the current Price Target for the Cullinan Oncology Inc stock?

The average Cullinan Oncology Inc target price is $35.19. This is 135.39% higher than the current stock price. The highest price target is 272.24%, the lowest is 82.41%. 14 Analysts have issued a price target Cullinan Oncology Inc 2027 .

How high will the Cullinan Oncology Inc stock rise?

No reliable answer can be given as to how high the Cullinan Oncology Inc stock will rise. The performance of stocks, including the Cullinan Oncology Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cullinan Oncology Inc stock today?

The performance of Cullinan Oncology Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cullinan Oncology Inc stock fall?

The decline in Cullinan Oncology Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cullinan Oncology Inc Forecast, price target & analysts

$14.95

0.95%

Nasdaq, Sep 28, 04:00 pm EDT.

ISIN

US2300311063

Symbol

CGEM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Cullinan Oncology Inc Target price 2026 - Analyst rating & recommendation

Cullinan Oncology Inc Classifications & Recommendation

Buy

95%

Hold

Cullinan Oncology Inc Price Target

Target Price	$35.19
Price	$14.95
Potential	135.39% register free of charge
Number of Estimates	14

	14 Analysts have issued a price target Cullinan Oncology Inc 2027 . The average Cullinan Oncology Inc target price is $35.19. This is 135.39% register free of charge higher than the current stock price. The highest price target is $55.65 272.24% register free of charge , the lowest is $27.27 82.41% register free of charge .
	A rating was issued by 19 analysts: 18 Analysts recommend Cullinan Oncology Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cullinan Oncology Inc stock has an average upside potential 2027 of 135.39% register free of charge . Most analysts recommend the Cullinan Oncology Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative
EV/Sales		42.99

15 Analysts have issued a Cullinan Oncology Inc forecast for earnings per share. The average Cullinan Oncology Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-2.68 17.54% unlock
2028	$-3.29 22.76% unlock
2029	$-2.87 12.77% unlock
2030	$-1.52 47.04% unlock
2031	$-2.57 69.08% unlock
2032	$-1.61 37.35% unlock
2033	$-0.53 67.08% unlock

Current	-4.50	165.95%
2026	-4.60 2.15% unlock
2027	-5.58 21.30% unlock
2028	-4.55 18.46% unlock
2029	-5.22 14.73% unlock
2030	-9.82 88.12% unlock
2031	-5.82 40.73% unlock
2032	-9.28 59.45% unlock
2033	-28.19 203.77% unlock

Cullinan Oncology Inc...

Current Cullinan Oncology Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 25 2026
BTIG	Locked ➜ Locked	Locked	Sep 25 2026
BTIG	Locked ➜ Locked	Locked	Sep 14 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 17 2026
Wedbush	Locked ➜ Locked	Locked	Aug 13 2026
BTIG	Locked ➜ Locked	Locked	Jul 29 2026
Wedbush	Locked ➜ Locked	Locked	Jun 11 2026

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 25 2026
Locked BTIG: Locked ➜ Locked	Sep 25 2026
Locked BTIG: Locked ➜ Locked	Sep 14 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 17 2026
Locked Wedbush: Locked ➜ Locked	Aug 13 2026
Locked BTIG: Locked ➜ Locked	Jul 29 2026
Locked Wedbush: Locked ➜ Locked	Jun 11 2026

Discover more stocks with a high price target

NIO ADR 104.00%

Alibaba Group Holding Ltd 73.67%

Rheinmetall 68.89%

Infineon 63.18%

Tencent Holdings Ltd. 58.19%

Adyen 55.40%

TUI 52.20%

BYD 51.64%

Uber Technologies 51.14%

Siemens Energy 48.42%

Adidas 41.08%

Netflix 39.97%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now